These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1811 related articles for article (PubMed ID: 18376186)
61. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction. Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033 [TBL] [Abstract][Full Text] [Related]
62. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction]. von Rahden BH; Feith M; Stein HJ Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774 [TBL] [Abstract][Full Text] [Related]
63. Minimally invasive esophagectomy for stage I and II esophageal cancer. Yamamoto S; Kawahara K; Maekawa T; Shiraishi T; Shirakusa T Ann Thorac Surg; 2005 Dec; 80(6):2070-5. PubMed ID: 16305846 [TBL] [Abstract][Full Text] [Related]
64. Outcomes after oesophagogastrectomy for carcinoma of the oesophagus. Omundsen M; Babor R; Johnston P ANZ J Surg; 2007; 77(1-2):37-9. PubMed ID: 17295818 [TBL] [Abstract][Full Text] [Related]
65. Intramucosal esophageal adenocarcinoma: primum non nocere. Li Z; Rice TW; Liu X; Goldblum JR; Williams SJ; Rybicki LA; Murthy SC; Mason DP; Raymond DP; Blackstone EH J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1519-24, 1524.e1-3. PubMed ID: 23158254 [TBL] [Abstract][Full Text] [Related]
66. What is an adequate extent of resection for T1 gallbladder cancers? You DD; Lee HG; Paik KY; Heo JS; Choi SH; Choi DW Ann Surg; 2008 May; 247(5):835-8. PubMed ID: 18438121 [TBL] [Abstract][Full Text] [Related]
67. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400 [TBL] [Abstract][Full Text] [Related]
68. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Konda VJ; Ross AS; Ferguson MK; Hart JA; Lin S; Naylor K; Noffsinger A; Posner MC; Dye C; Cislo B; Stearns L; Waxman I Clin Gastroenterol Hepatol; 2008 Feb; 6(2):159-64. PubMed ID: 18096439 [TBL] [Abstract][Full Text] [Related]
70. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma. Funai K; Sugimura H; Morita T; Shundo Y; Shimizu K; Shiiya N Ann Surg Oncol; 2011 Oct; 18(10):2968-72. PubMed ID: 21512862 [TBL] [Abstract][Full Text] [Related]
71. Effect of tumor characteristics and duplication of the muscularis mucosae on the endoscopic staging of superficial Barrett esophagus-related neoplasia. Mandal RV; Forcione DG; Brugge WR; Nishioka NS; Mino-Kenudson M; Lauwers GY Am J Surg Pathol; 2009 Apr; 33(4):620-5. PubMed ID: 19047893 [TBL] [Abstract][Full Text] [Related]
72. Effect of lymphatic mapping on diagnosis and treatment of patients with T1a, T1b favorable breast cancer. Jakub JW; Ebert MD; Diaz NM; Cantor A; Reintgen DS; Dupont EL; Shons AR; Cox CE Ann Surg; 2003 Jun; 237(6):838-41; discussion 841-3. PubMed ID: 12796580 [TBL] [Abstract][Full Text] [Related]
73. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [TBL] [Abstract][Full Text] [Related]
74. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy. Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024 [TBL] [Abstract][Full Text] [Related]
75. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Hölscher AH; Bollschweiler E; Schröder W; Metzger R; Gutschow C; Drebber U Ann Surg; 2011 Nov; 254(5):802-7; discussion 807-8. PubMed ID: 22042472 [TBL] [Abstract][Full Text] [Related]
76. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus. Chen G; Wang Z; Liu XY; Zhang MY; Liu FY Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712 [TBL] [Abstract][Full Text] [Related]
77. Lymph node metastasis in early esophageal adenocarcinoma. Griffin SM; Burt AD; Jennings NA Ann Surg; 2011 Nov; 254(5):731-6; discussion 736-7. PubMed ID: 21997815 [TBL] [Abstract][Full Text] [Related]
78. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience. González Ortiz DI; Toro DH Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980 [TBL] [Abstract][Full Text] [Related]
79. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580 [TBL] [Abstract][Full Text] [Related]
80. [Survival of patients with esophageal cancer subjected to total thoracic esophagectomy]. Braghetto I; Csendes A; Cornejo A; Amat J; Cardemil G; Burdiles P; Korn O Rev Med Chil; 2000 Jan; 128(1):64-74. PubMed ID: 10883524 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]